VictoryShares US 500 Enhanced Volatility Wtd ETF (CFO)

NASDAQ: CFO · Real-Time Price · USD
72.36
+0.34 (0.47%)
Jul 3, 2025, 1:00 PM - Market closed
0.47%
Assets $420.72M
Expense Ratio 0.37%
PE Ratio 20.92
Shares Out 5.85M
Dividend (ttm) $0.93
Dividend Yield 1.28%
Ex-Dividend Date Jun 9, 2025
Payout Frequency Monthly
Payout Ratio 26.85%
Volume 10,689
Open 72.30
Previous Close 72.02
Day's Range 72.25 - 72.47
52-Week Low 60.03
52-Week High 74.07
Beta 0.72
Holdings 505
Inception Date Jul 2, 2014

About CFO

Fund Home Page

The VictoryShares US 500 Enhanced Volatility Wtd ETF (CFO) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of the largest US stocks by market cap, screened for positive earnings and weighted by volatility. The fund can move to 75% cash maximum in market downturns. CFO was launched on Jul 2, 2014 and is issued by VictoryShares.

Asset Class Equity
Category Large Blend
Region North America
Stock Exchange NASDAQ
Ticker Symbol CFO
ETF Provider VictoryShares
Index Tracked Nasdaq Victory U.S. Large Cap 500 Long/Cash Volatility Weighted Index

Top 10 Holdings

3.42% of assets
Name Symbol Weight
Evergy, Inc. EVRG 0.38%
Linde plc LIN 0.37%
CME Group Inc. CME 0.35%
Atmos Energy Corporation ATO 0.34%
Marsh & McLennan Companies, Inc. MMC 0.34%
Automatic Data Processing, Inc. ADP 0.33%
The Coca-Cola Company KO 0.33%
Republic Services, Inc. RSG 0.33%
Cencora, Inc. COR 0.33%
Intercontinental Exchange, Inc. ICE 0.32%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Jun 9, 2025 $0.11262 Jun 10, 2025
May 8, 2025 $0.03005 May 9, 2025
Apr 10, 2025 $0.09739 Apr 11, 2025
Mar 10, 2025 $0.100 Mar 11, 2025
Feb 7, 2025 $0.0455 Feb 10, 2025
Jan 8, 2025 $0.11061 Jan 9, 2025
Full Dividend History

Performance

CFO had a total return of 14.44% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.45%.

News

Kashiv Biosciences Expands Leadership Team with New Chief Financial Officer and Chief Legal Officer

PISCATAWAY, N.J.--(BUSINESS WIRE)--Kashiv BioSciences, LLC, a global vertically integrated biopharmaceutical company, announced the appointment of Mandar Borkar as Global Chief Financial Officer (CFO)...

7 months ago - Business Wire

CFO: A Timing Methodology Failing For 10 Years

VictoryShares US 500 Enhanced Volatility Wtd ETF (CFO) combines low-volatility weighting with market timing. CFO's unconventional timing rules have reduced drawdown and volatility but result in lower ...

7 months ago - Seeking Alpha